advertisement
Fan S 24
Showing records 1 to 24 | Display all abstracts from Fan S80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Coleman RA
British Journal of Pharmacology 2019; 176: 687-698
80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adults
Fan S
British Journal of Ophthalmology 2019; 103: 1845-1849
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Woodward DF
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Coleman RA
British Journal of Pharmacology 2019; 176: 687-698
80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adults
Guo T
British Journal of Ophthalmology 2019; 103: 1845-1849
80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Woodrooffe AJ
British Journal of Pharmacology 2019; 176: 687-698
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Wang JW
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Woodrooffe AJ
British Journal of Pharmacology 2019; 176: 687-698
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Coleman RA
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Clark KL
British Journal of Pharmacology 2019; 176: 687-698
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Coleman RA
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adults
Chen B
British Journal of Ophthalmology 2019; 103: 1845-1849
80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Clark KL; Toris CB
British Journal of Pharmacology 2019; 176: 687-698
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Woodrooffe AJ; Woodrooffe AJ
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adults
Xiong J
British Journal of Ophthalmology 2019; 103: 1845-1849
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Clark KL; Clark KL
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adults
Havens S
British Journal of Ophthalmology 2019; 103: 1845-1849
80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Fan S; Wang JW
British Journal of Pharmacology 2019; 176: 687-698
80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adults
Gulati V
British Journal of Ophthalmology 2019; 103: 1845-1849
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Stamer WD
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80689 Differences in ocular biometrics and aqueous humour dynamics between Chinese and Caucasian adults
Toris CB
British Journal of Ophthalmology 2019; 103: 1845-1849
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Tao G
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
80215 The affinity, intrinsic activity and selectivity of a structurally novel EP receptor agonist at human prostanoid receptors
Woodward DF
British Journal of Pharmacology 2019; 176: 687-698
80927 A Highly Effective and Ultra-Long-Acting Anti-Glaucoma Drug, with a Novel Periorbital Delivery Method
Fan S; Toris CB
Journal of Ocular Pharmacology and Therapeutics 2019; 35: 265-277
